JPRN-jRCT2080220234未知3 期
Double-blind study of VAH631 in patients with essential hypertension (factorial study)
ovartis Pharma K.K.0 个研究点目标入组 558 人开始时间: 2006年4月21日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 发起方
- 入组人数
- 558
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 80age old（—）
- 性别
- All
入选标准
- •Inclusion criteria
- •- Essential hypertension measured by mercury sphygmomanometer
- •- Outpatients
- •- Male or female aged 20 to 80 years old
- •Exclusion criteria
- •- Secondary hypertension or suspected of having secondary hypertension.
- •- A history of malignant hypertension
- •- Severe hypertension
- •- Significant heart, renal, hepatic diseases or significant cerebrovascular disorder
- •Other protocol-defined inclusion/exclusion criteria may apply
排除标准
- 未提供
研究者
相似试验
未知
3 期
Double-blind study of VAA489 in patients with essential hypertension (factorial study)HypertensionJPRN-jRCT2080220350ovartis Pharma K.K.1,404
未知
3 期
ong term study of VAH631 in patients with essential hypertension (Extension from B1303 study)HypertensionJPRN-jRCT2080220261ovartis Pharma K.K.350
招募中
3 期
Phase III confirmatory study of in patients with venous malformation, lymphatic malformation and Klippel-Trenaunay SyndromeVenous malformation, Lymphatic malformation, Klippel-Trenaunay SyndromeJPRN-jRCT2041230064Hideki Kawabata32
已完成
3 期
A confirmatory study of SI-657 in Patients with Enthesopathy (Lateral Epicondylitis, Patellar Tendinitis, Achilles Tendinitis and Plantar Fasciitis)Enthesopathy (Lateral Epicondylitis, Patellar Tendinitis, Achilles Tendinitis and Plantar Fasciitis)JPRN-UMIN000010982KAKEN PHARMACEUTICAL CO., LTD/SEIKAGAKU CORPORATIO540
未知
2 期
Phase 2 Double-blind Study of S-525606 in Patients with Japanese Cedar Pollinosis Using an Pollen Challenge ChamberJapanese cedar pollinosisJPRN-jRCT2080222876Shionogi & Co., Ltd.